Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Challenge For Oral Delivery Of Middle-molecular Drugs: Use Of Osmolarity-sensitive Liposome As A Drug Carrier In The GI Tract

K. Minami, Asuka Takazawa, Yuki Taniguchi, Haruki Higashino, M. Kataoka, T. Asai, N. Oku, S. Yamashita
Published 2020 · Chemistry

Save to my Library
Download PDF
Analyze on Scholarcy
Abstract This study aims to develop a novel oral delivery system for middle-molecular drugs, such as bioactive peptides, using osmolarity-sensitive liposomes. Osmolarity-sensitive liposomes were prepared to include hypertonic sucrose solution (1.0 M) inside the liposomes (hypertonic liposomes) and were expected to release the encapsulated drug quickly depending on the osmotic difference between inside/outside the liposomes. As a first step, fluorescein isothiocyanate-dextran 4000 (FD-4), a non-degradable middle molecular compound, was used as a model drug. In vitro experiments were performed using dialysis film and Caco-2 cell monolayers to measure permeation rates of FD-4 from liposomes under various conditions. Liposomes composed of distearoylphosphatidylcholine (DSPC-Lip) showed a high stability in the intestinal fluid and released the encapsulated FD-4 depending on the osmotic difference. In contrast, liposomes composed of dipalmitoylphosphatidylcholine (DPPC-Lip) was unstable in the intestinal fluid to release FD-4 quickly regardless of the osmotic difference. Addition of cholesterol in DPPC improved the stability of liposomes whereas the encapsulated efficiency of FD-4 decreased. In vivo intestinal absorption of FD-4 from those liposomes well reflected in vitro observations. Hypertonic DSPC-Lip showed the highest absorption of FD-4 (about 20% dose/4 h s) which was more than 10-times higher than that from FD-4 solution. Observation of fluorescence intensity in the intestinal loop after incubation with FD-4 solution or DSPC-Lip demonstrated that liposomes can be retained in the intestinal tract for longer period. In conclusion, osmolarity-sensitive liposomes composed of DSPC lipid were proven to have a high potency to enhance the absorption of middle-molecular drugs having low membrane permeability.
This paper references
Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs.
Y. Hee Lee (2000)
Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
D. Liu (1999)
Oral Delivery of Peptide Drugs
J. Hamman (2012)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
J. Panyam (2003)
Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane
E. Khafagy (2015)
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
Peipei Guan (2011)
Oral Insulin Delivery: How Far are We?
P. Fonte (2013)
Cardiac profiles of liposomal anthracyclines
M. Theodoulou (2004)
Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems.
Dongdong Zhang (2016)
Nanoliposomal irinotecan for patients with metastatic pancreatic cancer
Y. Yamamoto (2017)
Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system.
M. Kataoka (2006)
Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma
J. García‐Marco (2009)
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.
T. Safra (2000)
Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study.
D. Vllasaliu (2012)
Influence of cholesterol on liposome stability and on in vitro drug release
Maria-Lucia Briuglia (2015)
Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.
T. Lindmark (1998)
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.
M. Niu (2014)
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
The effect of enzyme inhibitor and absorption site following [D‐ala2, D‐leu5]enkephalin oral administration in rats
H. J. Lee (2002)
Pitfall of tumor-bearing mouse models
K. Hyodo (2017)
In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
Haruki Higashino (2014)
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
T. A. Aguirre (2016)
Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Y. Katanasaka (2010)
Anticancer therapy using glucuronate modified long-circulating liposomes.
Oku (1999)
Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity
X. Zhang (2014)
Thiomers for oral delivery of hydrophilic macromolecular drugs
A. Bernkop-Schnürch (2004)
Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
S. B. Petersen (2012)
Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition.
M. Kokkona (2000)
Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.
C. Kirby (1980)
Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Z. Wu (2004)
Therapeutic nanosystems for oral administration of insulin.
F. A. do Carmo (2014)
Treatment of cerebral ischemia‐reperfusion injury with PEGylated liposomes encapsulating FK506
T. Ishii (2013)
Oral administration of insulin by encapsulation within liposomes
H. M. Patel (1976)
Biopharmaceutical Approaches for Developing and Assessing Oral Peptide Delivery Strategies and Systems: In Vitro Permeability and In Vivo Oral Absorption of Salmon Calcitonin
P. Sinko (2004)
Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery
L. Song (2014)

Semantic Scholar Logo Some data provided by SemanticScholar